MXCT
MaxCyte, Inc. · Healthcare
Casdin Partners Master Fund, L.P. sold $13.9M of MaxCyte, Inc.
10% owner
Sold$13,912,856
$4.30Price
3,235,548Shares
−23%Stake
What MXCT did after the filing
- The stock from Wed, Jul 6 close, $4.90
- +22.4%
- S&P 500, same days
- +11.3%
Measured over 30 trading days, to the Aug 17 close.
Traded Fri, Jul 1. Filed Wed, Jul 6, 1:01 PM ET, during the session. Returns use the Jul 6 close and the Aug 17 close. Not investment advice.